Oct 6, 2026
With more than 30 years of healthcare management experience, Thaddeus Thompson sets out the most consistent and costly valuation mistakes healthcare business owners make and why getting this wrong before a transaction begins can determine the outcome before negotiations ever start.
Boston, United States, October 6, 2026 -- With more than 30 years of healthcare management experience, Thaddeus Thompson sets out the most consistent and costly valuation mistakes healthcare business owners make and why getting this wrong before a transaction begins can determine the outcome before negotiations ever start.
UNITED STATES, August 2026
Thaddeus Thompson, Founder and Owner of Leland Healthcare Advisors and Consultants, a Fellow in the American College of Healthcare Executives and Member of the Alliance of Mergers and Acquisitions Advisors, has published guidance on one of the most consequential and consistently misunderstood stages of the healthcare business exit process: valuation.
In Thompson's experience working with lower-middle-market healthcare businesses across rehabilitation services, home health, behavioral health, and other clinical services, the gap between what a healthcare business owner believes their organization is worth and what the market will actually pay for it is one of the most reliable predictors of a transaction that either fails to close or closes badly. Understanding why that gap exists, and how to close it before the process begins, is, in his assessment, the single most important preparatory step available to a healthcare business owner considering an exit.
Why Healthcare Business Owners Consistently Overvalue Their Organizations
Thompson identifies several structural reasons that healthcare business owners arrive at inflated valuations. The first is revenue versus profitability confusion. Many owners calculate the value of their business based on its revenue rather than its profitability. Buyers, by contrast, most often evaluate businesses based on EBITDA, earnings before interest, taxes, depreciation, and amortization, and apply a multiple to that figure rather than to top-line revenue. A healthcare business generating $3 million in annual revenue with thin margins and high owner compensation drawn above market rate may have an EBITDA of $200,000 or less, producing a valuation significantly below what the revenue figure might suggest.
The second is the value of clinical relationships. Many healthcare business owners attribute significant value to the referral relationships, community reputation, and patient loyalty they have built over years or decades. Goodwill. These are real and meaningful assets, but their value in a transaction depends entirely on whether they are transferable to a new owner. Referral relationships that exist because of the personal credibility and relationships of the founding clinician or owner do not transfer automatically with the business. Buyers discount for this risk, often significantly.
The third is comparison to the wrong benchmarks. Healthcare business owners frequently cite the sale prices of other businesses they have heard about through their networks as evidence of what their own organization should be worth. Those comparisons rarely account for the specific financial profile, geographic market, service mix, payer mix, or owner dependency profile of the business being valued, all of which can move the multiple applied to EBITDA substantially in either direction.
What an Accurate Healthcare Business Valuation Requires
Thompson's approach to healthcare business valuation begins with a comprehensive financial analysis that establishes a realistic EBITDA figure after normalizing for owner compensation, one-time expenses, and non-recurring revenue items. That normalized EBITDA is then benchmarked against comparable transactions in the same healthcare subsector and geographic market to establish the range of multiples a buyer is likely to apply.
The resulting valuation range is then stress-tested against the specific risk factors present in the business, including owner dependency, payer mix concentration, regulatory compliance history, and the depth and transferability of the management team. Each of these factors can compress the multiple a buyer applies, and understanding their impact before the transaction process begins allows the seller to address them proactively rather than discovering them during due diligence when it is too late to respond.
"A healthcare business owner who goes to market without an accurate valuation is negotiating without a strong foundation," Thompson says. Significant asymmetry between seller’s and buyer’s valuations consistently derail negotiations."
About Leland Healthcare Advisors and Consultants
Leland Healthcare Advisors and Consultants Corp. is a healthcare and medtech business consulting and mergers and acquisitions advisory firm founded by Thaddeus Thompson. The firm provides business consulting, mergers and acquisitions advisory, growth planning, and operational improvement services to lower-middle-market healthcare businesses. Thaddeus Thompson is a Fellow in the American College of Healthcare Executives and a Member of the Alliance of Mergers and Acquisitions Advisors. For more information and to book a consultation, visit lelandhealthcare.org.
Contact Info:
Name: Xraised Media Desk
Email: Send Email
Organization: Leland Healthcare Advisors & Consultants
Website: https://lelandhealthcare.org
Release ID: 89205310
If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.
Nearly one in five marketing leaders has already eliminated roles because automation now handles the work. That is the finding behind a new Gartner prediction, which Marketing Week reported this week: by 2030, most high-performing marketing teams will be able to drop the traditional bottom rungs of the corporate ladder. The headline number is 18 […] The post Gartner says AI will kill the entry-level marketing job by 2030. Here’s why that’s the wrong takeaway appeared first on e27.
October looks like it could be crazy busy month for Apple and its users and fans.
In 2021, I invested in one of the robotics startups that was solving for real world problems. The idea was to look beyond the screen and make every hardware talking through new robo technology. My thesis was clear, after the software it’s hardware that will be disrupted. Since AI disrupted the market after 2022, my […] The post Why Southeast Asia’s VCs should pay attention to a16z’s new investment bet appeared first on e27.
The artificial intelligence investment story is beginning to move beyond the most obvious winners. For much of the past three years, the market’s attention has centred on graphics processing units (GPUs), high-bandwidth memory and the companies supplying the raw compute needed to train large AI models. That first wave is not over. But according to […] The post AI’s bottleneck economy is taking shape across Southeast Asia’s chip supply chain appeared first on e27.
The new DGX Spark retains the same GB10 Grace Blackwell Superchip as the 128GB model.
The most consequential AI launch of the past week was one that never happened. On the eve of its annual developer conference, OpenAI shelved GPT-6.1 Astra, the model expected to power ChatGPT and Codex next month and built to handle complex tasks with less human supervision. The reason was not that it was too weak. […] The post The agent that lied: what GPT-6.1 Astra’s cancellation means for Southeast Asia appeared first on e27.
Southeast Asia has become one of the world’s most competitive regions for investment. Global companies are diversifying supply chains beyond China. Governments are offering tax incentives, industrial land and digital-economy programmes. New capital is flowing into manufacturing, data centres, semiconductors and technology companies. Yet investors evaluating the region are looking beyond growth rates and startup […] The post Investors do not just fund startups. They fund predictability appeared first on e27.
The open-source startup Reflection AI released its first open-weight model Monday, stating it rivals leading open technologies made in the U.S. and China. Reflection AI, which has the backing of tech giant Nvidia, said in a blog post Monday its Beam model is on par with some leading open-source models made in China, including Chinese...
A major cryptocurrency super PAC is backing candidates in 32 House races with one month to go until the midterm elections. Fairshake is throwing its weight behind 13 Democrats and 19 Republicans, spokesperson Geoff Vetter confirmed to The Hill on Monday. The super PAC is spending $1 million each on six candidates — Reps. Janelle...
The Commodity Futures Trading Commission (CFTC) unveiled new proposals Monday for regulating cryptocurrency markets, after an effort to pass digital asset legislation through Congress came up short last month. The agency, one of two main financial regulators expected to oversee the industry, gave notice of its plans to move forward with rulemaking on both crypto...
The pop-up also features racing challenges, exclusive rewards and 10 life-sized LEGO F1 minifigures hidden around Suntec City.
Xiaomi’s wind-sculpted concept car will arrive alongside the PlayStation-exclusive game’s EV Experience mode.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.